Magnacet(TM) is the industry's only Oxycodone/Acetaminophen pain management
product providing 400mg of Acetaminophen
ST. LOUIS, June 7 /PRNewswire/ -- Mallinckrodt Brand Pharmaceuticals
today announced that it is providing a new pain management drug, called
Magnacet(TM) (oxycodone HCl /acetaminophen tablets CII). Magnacet is the
only available Oxycodone product coupled with 400mg of acetaminophen, a
unique dosage that gives physicians flexibility in treating patients with
moderate to moderately severe pain.
Magnacet is indicated for the relief of moderate to moderately severe
pain. The most frequently observed adverse reactions include
lightheadedness, dizziness, sedation, nausea and vomiting. Oxycodone can
produce drug dependence of the morphine-type and, therefore, has the
potential for being abused.
"Mallinckrodt Brands is committed to offering additional treatment
options that help healthcare providers improve patient care," says Marco
Polizzi, executive business director for Mallinckrodt Brand
Pharmaceuticals, a unit of Tyco Healthcare/Mallinckrodt. "Magnacet is an
example of our efforts to provide proven molecules in unique combinations
and strengths in an area such as pain, where it is important that medical
professionals are able to tailor treatments for specific needs of
patients."
According to Wolters Kluwer Health data, more than 200 million
prescriptions were written in the pain market in 2006, representing a 9
percent increase from the previous year. The U.S. Food and Drug
Administration (FDA) approved Magnacet in May 2006. The 400mg dose of
acetaminophen provides another option for physicians seeking additional
dosing flexibility in treating patients with moderate to moderately severe
pain.
Magnacet is available in 2.5/400, 5/400, 7.5/400, and 10/400mg tablets
through wholesalers and pharmacies in the United States. For more
information, including the full prescribing information, please call
Mallinckrodt at 1-888-744-1414.
About Mallinckrodt Pharmaceuticals Brands
Mallinckrodt Pharmaceuticals Brands division is dedicated to providing
quality pharmaceutical products to help healthcare professionals enhance
patient care. The organization consists of over 120 sales and marketing
personnel in the continental United States and is engaged in the promotion
of a broad range of medications focused on sleep, depression, palliative
care, pain management and other areas of the Central Nervous System. For
more information, visit http://www.pharmaceuticals.mallinckrodt.com/brand
or http://www.tycohealthcare.com.
About Tyco Healthcare/Mallinckrodt
Tyco Healthcare's Mallinckrodt division offers a diverse line of
imaging and pharmaceutical products that diagnose disease and relieve pain.
As a major business segment of Tyco International Ltd., Tyco Healthcare
manufactures, distributes and services an extensive product line including
disposable medical supplies, monitoring equipment, innovative wound closure
products, advanced surgical devices, medical instruments and bulk analgesic
pharmaceuticals. With industry-leading brand names such as Autosuture,
Kendall, Mallinckrodt, Nellcor, Puritan Bennett, Syneture and Valleylab,
Tyco Healthcare products are found in virtually every healthcare setting.
Trademarks are owned by Mallinckrodt Inc.
SOURCE Mallinckrodt Inc.
 back to top
Related links:
http://www.mallinckrodt.com
CONTACT:
JoAnna Schooler, Media Relations, Tyco
Healthcare Mallinckrodt, +1-314-654-3543,
joanna.schooler@tycohealthcare.com
|
